
The Institute for Apprenticeships (IFA) has approved its 300th apprenticeship standard for delivery – the Clinical Trials Specialist Degree Apprenticeship. Since implementing a new, streamlined approach, the Institute has seen a marked improvement in approval rates for standards delivery. In the last 6 months, the IFA has successfully supported trailblazers to develop and deliver 90 new standards alone. To date, this is the highest number of standards approved in any 6 month period since the reforms began, and twice the previous highest rate.
Sir Gerry Berragan, chief executive of the Institute for Apprenticeships, said: “With the faster and better programme, we’ve been working closely with trailblazers to get their proposals, standards and end-point assessment plans right first time, which has led to better outcomes for all involved. He continued: “Trailblazers are moving through the process quicker than before. However, quality is still very much at the centre of what we do.”
The UK government offers various apprenticeships to support the pharmaceutical industry, addressing skill gaps and providing an entry point for young professionals into the field. These apprenticeships are designed to give hands-on experience while earning industry-recognized qualifications. They offer a valuable pathway for individuals seeking careers in research, manufacturing, regulatory affairs, and other critical areas of the pharmaceutical sector. Key features of UK apprenticeships for the pharmaceutical industry includes:
Diverse Apprenticeship Levels
Targeted Apprenticeship Standards
The UK government and industry bodies, such as Cogent Skills and Life Sciences Skills Partnership, have developed specific standards that align with the needs of the pharmaceutical industry, including:
Industry Collaboration
Career Pathways and Benefits
The UK government provides funding for apprenticeship programs through initiatives like the Apprenticeship Levy, which requires large employers to contribute funds toward apprenticeship training. Employers in the pharmaceutical industry can benefit from this funding to upskill employees and address talent shortages, particularly in technical roles. UK apprenticeships play a critical role in supporting the pharmaceutical industry by offering structured, practical learning opportunities and addressing skills shortages. These programs help individuals develop careers in drug development, manufacturing, clinical trials, and regulatory compliance, while also benefiting pharmaceutical companies by fostering a skilled workforce tailored to industry needs. Through collaboration with educational institutions and government support, these apprenticeships ensure that the UK remains a leader in the global life sciences and pharmaceutical sectors.
Commissioned and delivered in just 10 months, the Clinical Trials Specialist Degree Apprenticeship, is proof that the Institute is committed to the faster and better reforms.
Hannah Barry, of GSK and chair of the Clinical Trials Specialist Trailblazer group, said: “In recent years, finding qualified and competent clinical trials specialists has become increasingly difficult. It isn’t something you hear about at careers fairs, and the opportunities for an amazing career in this area is not widely known." She also said: “The Clinical Trials Specialist Apprenticeship will open up another route to attract the best and most talented young students into the pharma industry."
The Level 6 qualification will be delivered over 4-5 years. Apprentices will receive a thorough background in the process of clinical research throughout the programme while also experiencing it first-hand. They will develop an understanding of the core science that underpins clinical trials. Through academic study, apprentices will gain the skills necessary to understand the scientific, regulatory, ethical and methodological issues involved in the design, conduct, analysis and reporting of clinical trials. While training, apprentices will work in operational roles where, under appropriate supervision, they will deliver the monitoring, oversight or project management aspects of clinical trials. On successful completion of their training, apprentices will be awarded full Bachelor of Science degrees where the education component is paid for by the apprenticeship levy.
John Cope, CBI Head of Education and Skills, said: “Reaching 300 new apprenticeship standards is a great achievement. The Institute for Apprenticeships’ commitment to speed up their approval and quality, as well as improve support for trailblazer groups is welcome. Businesses want to see these standards in place as soon as possible and the CBI will continue to support the Institute to do this.”
The Institute is on target to reach 400 standards approved for delivery by the end of this financial year. The strategic plan details the Board’s three guiding principles which should focus the way the Institute delivers, develops and works with others over the next five years. The business plan, aligned with the strategic principles, sets out our priorities and corporate objectives for the next financial year.
More detail on the 300th standard can be found on the IFAs website and you can view the apprenticeship's strategic plan and business plan here.


5th April 2017
- Tim Hardman
7th October 2012
- Tim Hardman
26th August 2015
- Tim Hardman
31st October 2021
- Tim Hardman
In the past, Halloween has meant the end of the crop and the start of the dark, cold winter.
4th August 2021
- Tim Hardman
Since 2013 we have been sharing our understanding on key issues with friends and clients via our Insider’s Insights.
29th March 2019
- Tim Hardman
29th March 2021
- Tim Hardman
24th August 2016
- Tim Hardman
25th February 2021
- Tim Hardman
4th May 2018
- Tim Hardman
31st October 2019
- Tim Hardman
1st April 2019
- Tim Hardman
9th May 2017
- Tim Hardman
9th January 2016
- Tim Hardman
30th March 2017
- Tim Hardman
14th February 2022
- Tim Hardman
12th May 2016
- Tim Hardman
21st December 2018
- Tim Hardman
30th April 2018
- Tim Hardman
12th February 2014
- Tim Hardman
27th April 2023
- Tim Hardman
15th August 2017
- Tim Hardman
5th May 2016
- Tim Hardman
20th December 2014
- Tim Hardman
7th July 2016
- Tim Hardman
16th June 2018
- Tim Hardman
16th May 2023
- Tim Hardman
Scientific knowledge should be accessible to all and if you are those communicating science
15th April 2019
- Tim Hardman
25th April 2019
- Tim Hardman
20th December 2017
- Tim Hardman
28th January 2018
- Tim Hardman
8th April 2019
- Tim Hardman
20th December 2012
- Tim Hardman
23rd December 2019
- Tim Hardman
Over the years friends, colleagues and industry leaders have shared their many of their insights with me freely
17th January 2018
- Tim Hardman
14th November 2017
- Tim Hardman
3rd August 2014
- Tim Hardman
31st January 2020
- Tim Hardman
We all need heroes - people who can champion our cause - helping the world to understand our rationale
4th April 2023
- Tim Hardman
1st October 2018
- Tim Hardman
25th October 2019
- Tim Hardman
11th September 2015
- Tim Hardman
14th February 2024
- Tim Hardman
We recently encouraged writers (of all kinds) in our recent Insider’s Insight to experiment with large language.
19th October 2022
- Tim Hardman
The internet was set alight last week on the issue of differences in the approach to emails adopted by men and women.
28th August 2018
- Tim Hardman
1st April 2023
- Tim Hardman
13th October 2023
- Tim Hardman
Paraskevidekatriaphobia is a phobia of Friday the 13th. Yes, they actually gave it a name.
21st December 2017
- Tim Hardman
28th March 2025
- Tim Hardman
20th April 2023
- Tim Hardman
Every year, a huge amount of scientific data is released. It's out there, but how do you find it?
20th June 2022
- Tim Hardman
I am continually reminded that I must work toward better relationships with my sons than the one I had with my dad.
15th February 2018
- Tim Hardman
7th July 2013
- Tim Hardman
15th April 2013
- Tim Hardman
6th September 2018
- Tim Hardman
1st July 2019
- Tim Hardman
24th March 2025
- Tim Hardman
19th May 2023
- Tim Hardman
4th May 2023
- Tim Hardman
Yes, it’s Star Wars Day again! The Star Wars films base their wow-factor on their adoption of science
19th May 2023
- Tim Hardman
31st January 2017
- Tim Hardman
12th July 2022
- Tim Hardman
14th March 2017
- Tim Hardman
16th April 2018
- Tim Hardman
5th August 2019
- Tim Hardman
Welcome to the seventh issue of the Refractory Asthma Stratification Programme (RASP-UK) newsletter
13th December 2018
- Tim Hardman
14th February 2022
- Tim Hardman
12th May 2020
- Tim Hardman
23rd May 2023
- Tim Hardman
I have never been great at conferences. People don’t believe me but I am painfully shy and far too worried about what.
9th May 2017
- Tim Hardman
19th October 2018
- Tim Hardman
20th December 2013
- Tim Hardman
27th February 2019
- Tim Hardman
12th July 2016
- Tim Hardman
17th July 2017
- Tim Hardman
4th May 2020
- Tim Hardman
2nd November 2023
- Tim Hardman
24th July 2024
- Tim Hardman
Congratulations class of 2024. That was all I needed to hear when I stood in your shoes almost 40 years ago. 40 years
24th February 2020
- Tim Hardman
Finding the best vehicle in which to publish your research findings is a perennial challenge.
9th February 2021
- Tim Hardman
11th May 2018
- Tim Hardman
Our team are exploring different and novel ways for young people to enter the pharmaceutical industry.
9th October 2017
- Tim Hardman
19th October 2018
- Tim Hardman
4th January 2019
- Tim Hardman
15th September 2015
- Tim Hardman
22nd January 2019
- Tim Hardman
14th August 2018
- Tim Hardman
The largest pharmaceutical companies not surprisingly rely on the largest contract research organizations
3rd July 2019
- Tim Hardman
4th February 2014
- Tim Hardman
16th August 2016
- Tim Hardman
14th April 2012
- Tim Hardman
4th June 2020
- Tim Hardman
19th November 2018
- Tim Hardman
The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)
19th June 2018
- Tim Hardman
Experience at Niche has taught us that clinical study protocols are born in the white-hot fire
11th November 2015
- Tim Hardman
20th April 2016
- Tim Hardman
3rd March 2015
- Tim Hardman
27th January 2023
- Tim Hardman
Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the.
18th April 2019
- Tim Hardman
Get our latest news and publications
Sign up to our news letterResources
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
Regular Updates

